Nutri-Pharm
 Addressing the Antimicrobial Drug Resistance (AMR) Crisis


The AMR Crisis


AMR is one of the worlds biggest health problems.


  • 1.27 million deaths directly due to AMR per year
  • 4.95 million deaths associated per year
  • Up to 10 million deaths per year by 2050

Based in Melbourne, Australia, Nutri-Pharm develops a range of products and technologies utilising specific combinations of organic compounds, selected on the basis of greatest potential for addressing the global Antimicrobial Drug Resistance (AMR) crisis. 

  • Nutri-Pharm antimicrobial design is for Multiple Components of known Antimicrobial Activity, conveying Multiple Mechanisms of Action. 
  • Non prescription OTC pathways for widespread preventative use.
  • Excellent Safety 
  • Potential Synergies with conventional antibiotics

NP Novel Approach

Many is Different (and better)


Unlike Conventional Antimicrobials which contain just one molecular type with one mechanism of action, Nutri-Pharm products utilise multiple molecular types with multiple mechanisms of antimicrobial action.

Water droplet on a blade of green grass, reflecting the surrounding greenery.
Double rainbow arches over a green, grassy cliffside overlooking the ocean; a cloudy sky.

Billions of water droplets create what one droplet can't.  Many is different.



Activity against AMR microbial species is specifically selected for in formulating, as is activity against key mechanisms of resistance development. 


Nutri-Pharm only selects components of excellent safety, very well known chemistry, pharmacology and stability with established regulatory status and sound commercial availability. 

Business as Usual

  • More antibiotics become ineffective
  • Higher medical and micro testing costs
  • Fewer preventative treatment options
  • 2nd/last-line antibiotics under pressure
  • Routine medical care risk

The Future with SPX9

  • Synergies with antibiotics improve their efficacy
  • Lower medical and micro testing costs
  • Simple, inexpensive preventative treatment
  • Many more treatment protocols available
  • Routine medical care made safer, easier, cheaper

Conventional Antibiotics  Versus The SPX9 Pathway

Conventional New Antibiotic SPX Pathway
Components with known Antimicrobial Action One Many
Mechanisms of Action One Several
Components known to Counter Resistance Development None Several
Associated Clinical Laboratory Testing and Costs Significant Less
Development Costs Very extensive costs Much less
Restrictions and Availability Limitations Heavily Restricted OTC
Preventative Use No Yes

Nutri-Pharm's Vision and Values

Our Vision is of a better and safer world through the benefit of anti-microbial technology.

Our purpose is to start with the Natural World's best anti-microbial compounds and elevate their effectiveness through research, understanding and technology.

Our mission is to address the growing crisis of anti-microbial drug resistance (AMR) with solutions of safety, adaptability and innovation through new thinking.

Our values of global care, respect, sustainability, excellence and diversity are embedded in our way of business.

Contact Us